Foxx Development (NASDAQ:FOXX) EVP Sells $14,941.14 in Stock

Foxx Development Holdings Inc. (NASDAQ:FOXX) EVP Haitao Cui sold 3,291 shares of Foxx Development stock in a transaction on Friday, March 20th. The stock was sold at an average price of $4.54, for a total transaction of $14,941.14. Following the completion of the transaction, the executive vice president directly owned 133,307 shares in the company, valued at $605,213.78. This represents a 2.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Haitao Cui also recently made the following trade(s):

• On Wednesday, March 18th, Haitao Cui sold 156 shares of Foxx Development stock. The stock was sold at an average price of $4.50, for a total value of $702.00.
• On Thursday, March 19th, Haitao Cui sold 603 shares of Foxx Development stock. The shares were sold at an average price of $4.56, for a total value of $2,749.68.

Foxx Development Price Performance

Foxx Development stock opened at $4.08 on Friday. Foxx Development Holdings Inc. has a 1-year low of $1.71 and a 1-year high of $8.88. The business has a fifty day moving average price of $4.54 and a 200-day moving average price of $4.39. The stock has a market capitalization of $28.60 million, a price-to-earnings ratio of -1.81 and a beta of -0.28.

Foxx Development (NASDAQ:FOXX) last announced its earnings results on Friday, February 13th. The company reported ($0.62) earnings per share (EPS) for the quarter. The company had revenue of $16.72 million during the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Foxx Development in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Foxx Development

An institutional investor recently raised its position in Foxx Development stock. JPMorgan Chase & Co. increased its position in Foxx Development Holdings Inc. (NASDAQ:FOXX) by 170.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,947 shares of the company’s stock after acquiring an additional 3,121 shares during the period. JPMorgan Chase & Co. owned approximately 0.07% of Foxx Development worth $27,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 60.44% of the company’s stock.

Foxx Development Company Profile

Foxx Development, Inc (NASDAQ: FOXX) operates as a contract manufacturer specializing in the design, assembly and distribution of medical devices and components. The company’s core business centers on phlebotomy and blood collection products, serving clinical laboratories, hospitals and diagnostic testing facilities. Its product portfolio includes evacuated blood collection tubes, safety-engineered winged blood collection sets, syringes and ancillary devices used in specimen collection and handling.

Founded in North Carolina, Foxx Development maintains a manufacturing and distribution campus in Apex, where it integrates engineering, quality control and regulatory compliance under one roof.